| Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity K Shinoda, R Li, A Rezk, I Mexhitaj, KR Patterson, M Kakara, L Zuroff, ... Proceedings of the National Academy of Sciences 120 (3), e2207291120, 2023 | 23 | 2023 |
| Improvement of refractory systemic juvenile idiopathic arthritis-associated lung disease with single-agent blockade of IL-1β and IL-18 JE Rood, A Rezk, J Pogoriler, LS Finn, JM Burnham, MB Josephson, ... Journal of Clinical Immunology 43 (1), 101-108, 2023 | 23 | 2023 |
| Immune aging in multiple sclerosis is characterized by abnormal CD4 T cell activation and increased frequencies of cytotoxic CD4 T cells with advancing age L Zuroff, A Rezk, K Shinoda, DA Espinoza, Y Elyahu, B Zhang, AA Chen, ... EBioMedicine 82, 104179, 2022 | 23 | 2022 |
| Abnormal B-Cell and Tfh-Cell Profiles in Patients With Parkinson Disease: A Cross-sectional Study R Li, TF Tropea, LR Baratta, L Zuroff, ME Diaz-Ortiz, B Zhang, K Shinoda, ... Neurology-Neuroimmunology Neuroinflammation 9 (2), 2022 | 35 | 2022 |
| Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy SA Apostolidis, M Kakara, MM Painter, RR Goel, D Mathew, K Lenzi, ... Nature medicine 27 (11), 1990-2001, 2021 | 444 | 2021 |
| Humoral and cell-based responses following SARS-CoV-2 mRNA vaccination of patients with multiple sclerosis on B-cell depleting therapy M Kakara, S Apostodolidis, M Painter, R Goel, D Mathew, K Lenzi, A Rezk, ... Multiple Sclerosis Journal, 78-79, 2021 | | 2021 |
| Cellular immune profiling pre-and post-aCD20 therapy points to differential effects on CD4 (+) and CD8 (+) T cells and implicates CD20-expressing CD8 (+) T cells in MS disease … K Shinoda, R Li, A Rezk, I Mexhitaj, KR Patterson, M Kakara, L Zuroff, ... | | 2021 |
| Characterization of age-related changes in circulating t cells in multiple sclerosis and normal controls: a pilot study L Zuroff, R Li, K Shinoda, A Rezk, A Bar-Or MULTIPLE SCLEROSIS JOURNAL 26 (3_ SUPPL), 570-570, 2020 | | 2020 |
| Resistance of cd11c (+) b cells to anti-cd20 depletion with treatment initiation and early preferential repopulation of anti-inflammatory b cells in ms K Shinoda, R Li, A Rezk, A Bar-Or MULTIPLE SCLEROSIS JOURNAL 26 (3_ SUPPL), 303-304, 2020 | | 2020 |
| Multiplexed detection and isolation of viable low-frequency cytokine-secreting human B cells using cytokine secretion assay and flow cytometry (CSA-Flow) A Rezk, R Li, A Bar-Or Scientific reports 10 (1), 1-10, 2020 | 6 | 2020 |
| Early Preferential Repletion Of Anti-inflammatory B Cells Following An Initial Cycle Of Ocrelizumab In Patients With Multiple Sclerosis K Shinoda, A Rezk, R Li, A Bar-Or MULTIPLE SCLEROSIS JOURNAL 26 (1_ SUPPL), 59-59, 2020 | | 2020 |
| B Cells Selectively Induce CD8+ MAIT Cell Effector Functions: Implications for Multiple Sclerosis (5355) A Rezk, K Shinoda, R Li, A Bar-Or Neurology 94 (15 Supplement), 2020 | | 2020 |
| Early preferential repopulation of anti-inflammatory B cells following an initial treatment of ocrelizumab in patients with multiple sclerosis (4770) K Shinoda, A Rezk, R Li, A Bar-Or Neurology 94 (15 Supplement), 2020 | 1 | 2020 |
| Pre-treatment T-cell subsets associate with fingolimod treatment responsiveness in multiple sclerosis M Ghadiri, A Rezk, R Li, A Evans, PS Giacomini, MH Barnett, J Antel, ... Scientific reports 10 (1), 1-14, 2020 | 30 | 2020 |
| Interactions between B cells and CD8+ T cells in multiple sclerosis A Rezk | | 2020 |
| Abnormal Frequency and Function of MR1-defined MAIT cells in Pediatric Multiple Sclerosis (S55. 007) I Mexhitaj, M Nyirenda, R Li, J O’Mahony, A Rezk, A Rosenberg, C Moore, ... Neurology 92 (15 Supplement), 2019 | 1 | 2019 |
| Assessing the Balance Between Effector and Regulatory T cell Subsets in Pediatric Multiple Sclerosis (S55. 006) I Mexhitaj, M Nyirenda, R Li, J O’Mahony, A Rezk, A Rosenberg, C Moore, ... Neurology 92 (15 Supplement), 2019 | | 2019 |
| Correction: Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple Sclerosis R Li, A Rezk, M Ghadiri, F Luessi, F Zipp, H Li, PS Giacomini, J Antel, ... The Journal of Immunology 202 (7), 2172-2172, 2019 | | 2019 |
| Abnormal effector and regulatory T cell subsets in paediatric-onset multiple sclerosis I Mexhitaj, MH Nyirenda, R Li, J O’Mahony, A Rezk, A Rozenberg, ... Brain 142 (3), 617-632, 2019 | 80 | 2019 |
| Functional Immune-phenotyping in Fingolimod-treated Multiple Sclerosis Patients: Assessing Drug Effects and Treatment Response Biomarkers M Ghadiri, A Rezk, R Li, PS Giacomini, J Antel, A Bar-Or MULTIPLE SCLEROSIS JOURNAL 25 (3), 444-444, 2019 | | 2019 |
